Etiology of autistic features: the persisting neurotoxic effects of propionic acid

[1]  M. Kotb,et al.  Etiology of autistic features: the persisting neurotoxic effects of propionic acid , 2012, Journal of Neuroinflammation.

[2]  M. Kavaliers,et al.  Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats , 2012, Behavioural Brain Research.

[3]  G. Hatch,et al.  Fatty acid transport into the brain: of fatty acid fables and lipid tails. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[4]  A. El-Ansary,et al.  Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia , 2011, Journal of Neuroinflammation.

[5]  E. Azmitia,et al.  Dystrophic Serotonin Axons in Postmortem Brains from Young Autism Patients , 2011, Anatomical record.

[6]  Aletta D Kraneveld,et al.  Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. , 2011, European journal of pharmacology.

[7]  E. Azmitia,et al.  Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors , 2011, Neuropharmacology.

[8]  A. El-Ansary,et al.  Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia , 2011, Lipids in Health and Disease.

[9]  A. El-Ansary,et al.  Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia , 2011, Lipids in Health and Disease.

[10]  J. Wegiel,et al.  Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism , 2011, Journal of neurochemistry.

[11]  G. Blatt,et al.  Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism , 2011, Brain Research.

[12]  D. Cain,et al.  Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder , 2011, Behavioural Brain Research.

[13]  Paula Krakowiak,et al.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome , 2011, Brain, Behavior, and Immunity.

[14]  D. Austin,et al.  Autistic disorder and phospholipids: A review. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  M. Majewska,et al.  Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal. , 2010, Folia neuropathologica.

[16]  D. Sparks,et al.  Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells , 2009, Neuroscience.

[17]  D. Amaral,et al.  Animal models of autism spectrum disorders: information for neurotoxicologists. , 2009, Neurotoxicology.

[18]  A. El-Ansary,et al.  Metabolic biomarkers related to energy metabolism in Saudi autistic children. , 2009, Clinical biochemistry.

[19]  A. El-Ansary,et al.  Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. , 2009, Clinical biochemistry.

[20]  Sangita B. Patil,et al.  Elevated immune response in the brain of autistic patients , 2009, Journal of Neuroimmunology.

[21]  M. Jakowec,et al.  Molecular Differences in the Fischer 344 Rat, A New Animal Model of Autism , 2009 .

[22]  G. Juckel,et al.  Dopamine and serotonin levels following prenatal viral infection in mouse—Implications for psychiatric disorders such as schizophrenia and autism , 2008, European Neuropsychopharmacology.

[23]  D. Cain,et al.  Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism , 2008, Neuropharmacology.

[24]  M. Matsui,et al.  Essential polyunsaturated fatty acids and social cognition in schizophrenia , 2008, Psychiatry Research.

[25]  Francis Boon,et al.  Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders , 2007, Behavioural Brain Research.

[26]  Rita Banzi,et al.  Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders , 2006, International clinical psychopharmacology.

[27]  S. Milstien,et al.  Cerebrospinal fluid and serum markers of inflammation in autism. , 2005, Pediatric neurology.

[28]  N. Bazan.  Neuroprotectin D1 (NPD1): A DHA‐Derived Mediator that Protects Brain and Retina Against Cell Injury‐Induced Oxidative Stress , 2005, Brain pathology.

[29]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[30]  G. Young,et al.  Omega-3 fatty acids and neuropsychiatric disorders. , 2005, Reproduction, nutrition, development.

[31]  C. Lawler,et al.  Identifying environmental contributions to autism: provocative clues and false leads. , 2004, Mental retardation and developmental disabilities research reviews.

[32]  W. McGinnis.  Oxidative stress in autism. , 2004, Alternative therapies in health and medicine.

[33]  M. Wajner,et al.  The role of oxidative damage in the neuropathology of organic acidurias: Insights from animal studies , 2004, Journal of Inherited Metabolic Disease.

[34]  S. Zoroglu,et al.  Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[35]  V. Pieribone,et al.  Midbrain serotonergic neurons are central pH chemoreceptors , 2003, Nature Neuroscience.

[36]  M. Vacca,et al.  [3 H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions , 2003, Neurochemistry International.

[37]  M. Haag,et al.  Essential Fatty Acids and the Brain , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[38]  O. Yorbik,et al.  Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[39]  M. Kato,et al.  Increased Monoamine Concentration in the Brain and Blood of Fetal Thalidomide- and Valproic Acid–Exposed Rat: Putative Animal Models for Autism , 2002, Pediatric Research.

[40]  J. Dambrosia,et al.  Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation , 2001, Annals of neurology.

[41]  U. Bonnet,et al.  Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones , 2000, European Neuropsychopharmacology.

[42]  W. Fenton,et al.  Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia , 2000, Biological Psychiatry.

[43]  F. Zacchello,et al.  Clinical and biochemical approach to the neonate with a suspected inborn error of amino acid and organic acid metabolism. , 1999, Seminars in perinatology.

[44]  G. Gobbel,et al.  Blood-brain barrier disruption, HSP70 expression and apoptosis due to 3-nitropropionic acid, a mitochondrial toxin. , 1997, Acta neurochirurgica. Supplement.

[45]  E. Lock,et al.  l-2-Chloropropionic acid metabolism and disposition in male rats: relevance to cerebellar injury , 1997, Archives of Toxicology.

[46]  M. Ruiz-Larrea,et al.  Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes , 1994, Steroids.

[47]  I. Tannock,et al.  Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. , 1993, British Journal of Cancer.

[48]  P. Goldman-Rakic,et al.  Commentary: the acquisition and use of human brain tissue in neuropsychiatric research. , 1991, Schizophrenia bulletin.

[49]  A. Schroit,et al.  Maintenance of lipid asymmetry in red blood cells and ghosts: effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine. , 1990, Biochimica et biophysica acta.

[50]  C. Barthélémy,et al.  Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children , 1986, Journal of autism and developmental disorders.

[51]  R. D. Steele,et al.  Characterization of alpha-keto acid transport across blood-brain barrier in rats. , 1983, The American journal of physiology.

[52]  S. Jagota,et al.  A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent. , 1982, Analytical biochemistry.

[53]  J. Henry.  Clinical diagnosis and management by laboratory methods , 1979 .

[54]  D. Rodgerson,et al.  Proceedings of the Second International Symposium on Clinical Enzymology , 1976 .

[55]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[56]  E. Beutler,et al.  Improved method for the determination of blood glutathione. , 1963, The Journal of laboratory and clinical medicine.

[57]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.